September 14, 2020 | New York Law Journal
Patent Issues Highlight Risks of Moderna's COVID-19 VaccineModerna's COVID-19 vaccine represents one of our best hopes for overcoming the pandemic; however, several unresolved patent issues are brewing in the background, underlying the substantial risks and significant potential rewards of Moderna's vaccine.
By Dorothy R. Auth and Michael B. Powell
8 minute read
Trending Stories